Princeton Consumer Research
Raritan, New Jersey, 08869, United States
NCT Number: NCT06977854
Citrulline dietary supplements are of interest for improving cardiovascular and exercise performance. The health benefits of citrulline are attributable to its ability to increase arginine levels in the body through the intestinal-renal arginine conversion pathway. From a dietary supplementation standpoint, citrulline offers advantages over arginine due to its reduced first-pass metabolism and ready conversion to arginine within the body. While L-citrulline is the most widely used citrulline dietary supplement, additional salt forms such as citrulline maleate and citrulline HCl may provide improvements in the delivery of arginine to the body. The present study compared the single-dose pharmacokinetics of L-citrulline and citrulline HCl formulations in healthy human subjects. A total of 17 subjects were randomly assigned to groups receiving either 6 g of L-citrulline, 6 g of citrulline HCl or 2 g of citrulline HCl. The resulting increases in citrulline and arginine in plasma and urine samples were determined using liquid chromatography-multiple reaction monitoring mass spectrometry (LC-MRM/MS). All citrulline dietary supplements examined produced time-dependent increases in plasma citrulline and arginine. Both maximal plasma concentration (Cmax) and area under the plasma vs time curve (AUC) for citrulline were modestly reduced in the 6 g citrulline HCl treatment group, the resulting arginine Cmax and AUCs were similar for both L-citrulline and citrulline HCl at the 6 g dose. While the 2 g dose of citrulline HCl had reduced Cmax and AUC values compared to 6 g doses, the time to reach peak levels of arginine were significantly shorter. Furthermore, examination of the relative arginine bioavailability achieved with the 6 g and 2 g citrulline HCl compared to the 6 g L-citrulline was approximately 120% and 215%, respectively, consistent with an improved citrulline to arginine conversion efficiency with the citrulline HCl formulations.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Observational
Raritan, New Jersey, 08869, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participation of a subject in this study may have been discontinued for any of the following reasons:
The participation of a subject in this study may have been discontinued for any of the following reasons:
Time frame: 0-180 minutes
Measured blood plasma arginine levels at various time points.
Vireo Systems, Inc.
Industry
A SINGLE CENTER, SINGLE-BLIND STUDY DESIGN IN HEALTHY SUBJECTS TO EVALUATE SEVERAL EFFECTS OF CITRULLINE SUPPLEMENTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06774911
Bioavailability and AUC, Biological Availability
Reus, Spain
View Trial DetailsNCT06686004
Absorption, Metabolism and Excretion in Healthy Volunteers, Bioavailability and AUC
Newcastle upon Tyne, Tyne and Wear, United Kingdom
View Trial DetailsNCT01635985
Bioavailability and AUC
London, UK, United Kingdom
View Trial DetailsNCT07508735
Bioavailability Heathy Volunteers, Bioavailability and AUC
Madrid, Spain
View Trial Details